G. Marinucci
About
In The Last Decade
G. Marinucci
29 papers receiving 571 citations
Peers
Comparison fields: 5 of 39
- Epidemiology 471
- Hepatology 470
- Immunology 87
- Agronomy and Crop Science 62
- Surgery 59
Countries citing papers authored by G. Marinucci
This map shows the geographic impact of G. Marinucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Marinucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Marinucci more than expected).
Fields of papers citing papers by G. Marinucci
This network shows the impact of papers produced by G. Marinucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Marinucci. The network helps show where G. Marinucci may publish in the future.
Co-authorship network of co-authors of G. Marinucci
This figure shows the co-authorship network connecting the top 25 collaborators of G. Marinucci. A scholar is included among the top collaborators of G. Marinucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Marinucci. G. Marinucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF. | 3 |
| 3 | Livers of mice transgenic for human CD46 are protected from human complement attack | 6 |
| 4 | 10 | |
| 5 | 54 | |
| 6 | 19 | |
| 7 | 107 | |
| 8 | 10 | |
| 9 | Long term treatment of chronic delta hepatitis with alpha recombinant interferon. | 6 |
| 10 | 7 | |
| 11 | 5 | |
| 12 | Results of liver transplantation for hepatitis delta disease without immunoprophylaxis. | 6 |
| 13 | 3 | |
| 14 | 76 | |
| 15 | Infezioni da HBV e HDV nei pazienti in trattamento emodialitico cronico. | 4 |
| 16 | [HBV and HDV infection in chronic hemodialysis treatment patients]. | 1 |
| 17 | 52 | |
| 18 | 36 | |
| 19 | Spread of delta infection in a group of haemodialysis carriers of HBsAg. | 2 |
| 20 | Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease. | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.